Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal M Morel

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 28, 2018
Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation IncentivesChantal M Morel, Suzanne E Edwards
Health Affairs (Project Hope)|August 9, 2011
The level of income appears to have no consistent bearing on pharmaceutical prices across countriesChantal M Morel, Alistair McGuire, Elias Mossialos
The Journal of Antibiotics|March 5, 2021
Market concentration of new antibiotic salesSakib Rahman, Olof Lindahl, Chantal M Morel, et al.
BMJ (Clinical Research Ed.)|November 12, 2005
Cost effectiveness analysis of strategies to combat malaria in developing countriesChantal M Morel, Jeremy A Lauer, David B Evans
Antibiotics (Basel, Switzerland)|December 21, 2018
Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?Suzanne E Edwards, Chantal M Morel, Reinhard Busse, et al.
Frontiers in Medicine|May 6, 2021
Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment OptionsChantal M Morel, Marlieke E A de Kraker, Stephan Harbarth, et al.
American Journal of Law & Medicine|November 1, 2017
Exploring the Obstacles to Implementing Economic Mechanisms to Stimulate Antibiotic Research and Development: A Multi-Actor and System-Level AnalysisEnrico Baraldi, Francesco Ciabuschi, Ross Leach, et al.
Plos Medicine|June 15, 2016
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into RealityKevin Outterson, Unni Gopinathan, Charles Clift, et al.
BMJ Open|July 7, 2023
Multisystemic resilience to shocks: a temporal analysis of health, fundamental rights and freedoms, and economic resilience during the first wave of the COVID-19 pandemic in 22 European countriesMia Clausin, Alicia Rieckhoff, Fabrizio Tediosi, et al.
BMJ Global Health|December 12, 2017
Mapping global policy discourse on antimicrobial resistanceDidier Wernli, Peter S Jørgensen, Chantal M Morel, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 28, 2018
Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation IncentivesChantal M Morel, Suzanne E Edwards
Health Affairs (Project Hope)|August 9, 2011
The level of income appears to have no consistent bearing on pharmaceutical prices across countriesChantal M Morel, Alistair McGuire, Elias Mossialos
The Journal of Antibiotics|March 5, 2021
Market concentration of new antibiotic salesSakib Rahman, Olof Lindahl, Chantal M Morel, et al.
BMJ (Clinical Research Ed.)|November 12, 2005
Cost effectiveness analysis of strategies to combat malaria in developing countriesChantal M Morel, Jeremy A Lauer, David B Evans
Antibiotics (Basel, Switzerland)|December 21, 2018
Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?Suzanne E Edwards, Chantal M Morel, Reinhard Busse, et al.
Frontiers in Medicine|May 6, 2021
Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment OptionsChantal M Morel, Marlieke E A de Kraker, Stephan Harbarth, et al.
American Journal of Law & Medicine|November 1, 2017
Exploring the Obstacles to Implementing Economic Mechanisms to Stimulate Antibiotic Research and Development: A Multi-Actor and System-Level AnalysisEnrico Baraldi, Francesco Ciabuschi, Ross Leach, et al.
Plos Medicine|June 15, 2016
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into RealityKevin Outterson, Unni Gopinathan, Charles Clift, et al.
BMJ Open|July 7, 2023
Multisystemic resilience to shocks: a temporal analysis of health, fundamental rights and freedoms, and economic resilience during the first wave of the COVID-19 pandemic in 22 European countriesMia Clausin, Alicia Rieckhoff, Fabrizio Tediosi, et al.
BMJ Global Health|December 12, 2017
Mapping global policy discourse on antimicrobial resistanceDidier Wernli, Peter S Jørgensen, Chantal M Morel, et al.
Pageof 2